User:Judika39

Nzedegwu Robert Olisa, III is an American humanitarian, and author. He was born in 1967 at Onitsha, Nigeria, but shortly thereafter immigrated to the US in 1971 as an infant. He is Founder and Chief Executive Officer at Olisa Research, USA12 (Formerly Biological Agents Corporation2,3,10,11,12,23 USA, or BAC), an income generating subsidiary of the Texas non-profit Olisa Foundation.4,8,7,9 The foundation trades as BAC Pharmaceuticals,19 American Journal of Biological Defense, 20 and International Molecular Diagnostic and Research Laboratories. 21 Olisa is a pioneer of applied Proteomics, and Computational Biology.13,14,15,16,17,18,25 He has a United States patent and several United States Library of Congress copyrights in this area. Before obtaining Master’s degrees in Biological Sciences (1996) and Public Administration (2006) at University of Texas El Paso he obtained a diploma in Medical Technology from the Armed Forces Academy for Health Sciences in San Antonio, Texas. He was an aspiring doctoral student at Open University, San Diego State University in California (1997), Howard University in Washington DC (1998-2003), and at the Universitaet Tübingen Germany where he studied under Volkmar Braun (2002-2004). In 2008, he and his legal team issued ‘cease and desist’ letters to several academic and corporate institutions in the United States and Europe for Copyrights and Patent infringements of his proteomics technologies.1 In addition, they filed complaints with the Federal Bureau of Investigations (FBI), National Science Foundation (NSF), and National Institutes of Health (NIH).

Military Olisa enlisted in the US Army in 1993, and performed basic infantry training at Ft. Leonard Wood, Missouri, and Advanced Training as a Medical Technologist at Armed Forces Academy for Health Sciences, San Antonio Texas. After selection for officer candidacy, he attended Officer Indoctrination School (OIS) at New Port, Rhode Island and received a direct commission in the United States Navy Medical Services Corps in 1996. He transferred into the Naval Reserves in 1998. He was awarded the Armed Forces Expeditionary Medal in 1996 in recognition of his service in the Middle East. Occupations practiced in the Naval Reserves by Olisa include Microbiologist, Industrial Hygienist, Environmental Health Officer, Healthcare Administrator, Medical Planner, and Public Health Administrator.

Early Education Olisa started his education by attending St. Catherine’s Laborè (grade school) Wheaton Maryland, USA (1972-1977). He attended Saint Joseph’s College (middle school) Vom, Nigeria (1978-1980), Federal Government College (high school), Jos, Nigeria (1980-1983), Uthman Dan Fodio University Sokoto, Nigeria (1984). Olisa briefly studied Medicine at the University of Jos Nigeria but transferred to the Natural Sciences where he received an undergraduate degree in Zoology in 1990. During this time, while in Africa in the ‘80s, he developed an interest in HIV/AIDS research. After graduation he enlisted info the United States Army in 1993.

Discovery and Invention Robert started his research corporation in 1998 while attending graduate school at the San Diego State University. 2 His first invention was originally based on a United States Department of Defense research project which he wanted to convert to a thesis proposal for graduate work at the San Diego State University. During this time he created a standard online algorithm for contagions risk management.15, 16,17,18,25 His algorithm has been packaged into software that is currently marketed as the SurgeForcast1.0. In 2007 he was awarded the first US patent issued for a utility in proteomics (patent was filed in April 23, 2003).15 In summary, the patent is for the invention of a new biochemical (braunmycin) 22 and a its usefulness in the process of proteomics. The patent also includes the discovery of new composition of matter (Olisferrol) 5,6 associated with his invention. The original idea of this invention was based on his doctoral research at Howard University in Washington DC and Universitaet Tübingen in Germany. In 2002, while he working for his research corporation at the dorm rooms of Howard University he invented and formulated a biochemical for iron-affinity chromatography named braunmycin (C6H12FeN06)22 after Volkmar Braun. Additionally, while at Howard University he developed a technique for purifying and characterizing iron-binding proteins in DNA cells using braunmycin and partial genomic and proteomic databases available at the time.13,14,17,18,25 for his effort he was awarded the Charles Ireland first place Prize for medical research by the Howard University Hospital. Seven years later the United States Government awarded him a patent for a utilities associated with his discoveries and invention. While studying abroad as a guest doctoral student in Germany he discovered Olisferrol (C119H163Fe2N29071S4)5,6 or Ferrous Methiolate25 an organic supplement derived from and identical to an Echinacea root extract that supports the immune system in clinical and animal studies.25,26 Collectively, his pharmaceutical and medical technologies are currently used in early cancer detection, immune therapeutics, and contagions risk management. Writings Olisa’s book, Biological Agents Index: Risk Management Strategies for Contagions17, 18, 25 is in its fourth edition and is published by an Olisa Foundation company called American Journal of Biological Defense (ISSN 1941 4048). The book is based on concepts in Macroeconomics and there uses in Medicine.

www.olisa.orgwww.olisferrol.comwww.braunmycin.comwww.BiologicalAgents.com